The document discusses the potential for 3D printing of oral drugs to help address issues arising during the COVID-19 pandemic. It provides an introduction to 3D printing, describing its history and various applications such as in biomedicine and healthcare. The document then discusses how 3D printing of drugs could help with dose changes for pediatric/geriatric patients, clinical trials of multi-drug combinations, and decentralized production in areas impacted by supply chain problems during the pandemic. It concludes by citing references examining personalizing drug products using 3D printing and how 3D printing could help fight future crises like COVID-19.